Effects and actions of EM (erythromycin) , CAM (clarithromycin) , and JM (josamycin) on IL-4 and IL-5 production by monocytes
Tei, A.; Mineshita, M.; Haruta, Y.; Ishioka, S.; Yamakido, M.
Japanese Journal of Antibiotics 50 Suppl A: 110-112
1997
ISSN/ISBN: 0368-2781 PMID: 9597458 Document Number: 484045
Document emailed within 1 workday
Related Documents
Ohtomo, T.; Ohshima, Y.; Usui, Y.; Ichiman, Y.; Yanagisawa, N.; Yokota, E.; Shimada, J. 1995: Effect of sub-inhibitory concentrations of clarithromycin and erythromycin on the production of Staphylococcus aureus capsules Journal of ChemoTherapy 7(Suppl 4): 9-11Yamauchi, Y.; Kouyama, T.; Itakura, S.; Kamiya, S.; Nagase, T.; Sunazuka, T.; Omura, S.; Takizawa, H. 2009: The effects of macrolides (EM900, clarithromycin and azithromycin) on IL-17-induced IL-8 production by airway epithelial cells Japanese Journal of Antibiotics 62 Suppl A: 17-21
Takeshita, K.; Yamagishi, I.; Harada, M.; Otomo, S.; Nakagawa, T.; Mizushima, Y. 1989: Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages Drugs under Experimental and Clinical Research 15(11-12): 527-533
Rolin, O.; Bouanchaud, D.H. 1989: Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus Pathologie-Biologie 37(5): 375-377
Fritzenwanger, M.; Jung, C.; Franz, M.; Foerster, M.; Figulla, H.R. 2012: Immunomodulatory effects of cardiotrophin-1 on in vitro cytokine production of monocytes and CD4 + T-lymphocytes Indian Journal of Medical Research 136(3): 471-476
Pue, C.A.; Mortensen, R.F.; Marsh, C.B.; Pope, H.A.; Wewers, M.D. 1996: Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages Journal of Immunology 156(4): 1594-1600
Benninger, P.; Cooper, A.; Moisan, R.; Patel, P.; Elvin, A.; Thiessen, J.J. 2004: A comparative clarithromycin bioavailability study: determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions International Journal of Clinical Pharmacology and Therapeutics 42(6): 342-349
Zheng, X.-L.; Hu, F.-L.; Wang, W.-H.; Xu, L. 2009: Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains Zhonghua Yi Xue Za Zhi 89(22): 1558-1562
Yamamoto, F.; Harada, S.; Mitsuyama, T.; Harada, Y.; Kitahara, Y.; Yoshida, M.; Nakanishi, Y. 2004: Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin Japanese Journal of Antibiotics 57(1): 124-133
Danis, V.A.; Kulesz, A.; Nelson, D.S.; Brooks, P.M. 1989: Bimodal effect of gold on IL-1 production by blood monocytes Journal of Rheumatology 16(8): 1160-1161
Donnelly, R.P.; Fenton, M.J.; Finbloom, D.S.; Gerrard, T.L. 1990: Differential regulation of IL-1 production in human monocytes by IFN-gamma and IL-4 Journal of Immunology 145(2): 569-575
Liou, J-Ming.; Chen, C-Yi.; Wu, M-Shiang.; Hsu, M-Tse.; Fang, C-Chung.; Lin, Y-Ling.; Chang, M-Chu.; Lin, J-Town.; Wang, H-Po. 2006: Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease Hepato-Gastroenterology 53(71): 792-796
Koval'chuk, L.V.; Cheredeev, A.N.; Izbekova, V.A.; Konstantinov, A.A.; Nemechek, I.B. 1986: Interleukin-1 and prostaglandin production by human peripheral blood monocytes Laboratornoe Delo 11: 657-660
Matsumoto, K. 1989: Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis Clinical Nephrology 31(6): 292-296
Arend, W.P.; Massoni, R.J.; Niemann, M.A.; Giclas, P.C. 1989: Absence of induction of IL-1 production in human monocytes by complement fragments Journal of Immunology 142(1): 173-178
McMillen, M.A.; Huribal, M.; Cunningham, M.E.; Kumar, R.; Sumpio, B.E. 1995: Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6 Critical Care Medicine 23(1): 34-40
Hofstetter, C.; Kleen, M.; Habler, O.; Allmeling, A.M.; Krombach, F.; Zwissler, B. 1998: Recombinant human interleukin-10 attenuates TNFalpha production by porcine monocytes European Journal of Medical Research 3(6): 299-303
Shao, L.; Frigon, N.L.; Sehy, D.W.; Yu, A.L.; Lofgren, J.; Schwall, R.; Yu, J. 1992: Regulation of production of activin a in human marrow stromal cells and monocytes Experimental Hematology 20(10): 1235-1242
Mengozzi, M.; Fantuzzi, G.; Sironi, M.; Bianchi, M.; Fratelli, M.; Peri, G.; Bernasconi, S.; Ghezzi, P. 1993: Early down-regulation of TNF production by LPS tolerance in human monocytes: comparison with IL-1 beta, IL-6, and IL-8 Lymphokine and Cytokine Research 12(4): 231-236
Majer, J.; Stanaszek, R.S.; Mueller, S.L.; Marti, G. 1978: N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(6): 673-676